Lineage-specific survival signal of lung adenocarcinoma on the lung
Lineage-specific survival signal of lung adenocarcinoma on the lung
批准号:
22790753
负责人:
YAMAGUCHI Tomoya
金额:
$2.5万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Young Scientists (B)
财政年份:
2010
资助国家:
日本
项目状态:
已结题
起止时间:
2010 至 2011
中文摘要
TTF-1的持续表达在肺腺癌的生存中起着至关重要的作用,除了正常肺中细胞谱系的发育和维持之外。在这项研究中,我们确定了DOT-2,作为TTF-1调节基因,我们表明,DOT-2抑制组装能力赋予磷酸化的肌球蛋白调节轻链(RLC)以及激活磷酸化的LIM结构域激酶(LIMK),出乎意料地通过其直接的物理相互作用与Rho激酶1(ROCK 1),而不是与RLC。因此,DOT-2抑制ROCK 1并负调节肌动球蛋白组织,这反过来又降低了单个细胞的运动性并增加了集体细胞迁移,从而降低了癌症的侵袭和转移。最后,我们还表明,DOT-2是表观遗传失活的启动子DNA甲基化的一部分TTF-1阳性肺腺癌,这似乎是根据其有害的功能,肺腺癌的侵袭和转移,以及矛盾的关联TTF-1表达与肺腺癌患者的良好预后。
英文摘要
Sustained TTF-1 expression plays a crucial role in the survival of lung adenocarcinoma, in addition to the development and maintenance of cell lineages in normal lung. In this study, we identified DOT-2, as a TTF-1-regulated gene, and we showed that DOT-2 inhibited assembly competence-conferring phosphorylation of the myosin regulatory light chain(RLC) as well as activating phosphorylation of LIM domain kinase(LIMK), unexpectedly through its direct physical interaction with Rho kinase 1(ROCK1) rather than with RLC. Consequently, DOT-2 inhibited ROCK1 and negatively regulated actomyosin organization, which in turn reduced single cell motility and increased collective cell migration, resulting in decreased cancer invasion and metastasis. Finally, we also show that DOT-2 is epigenetically inactivated by promoter DNA methylation in a fraction of TTF-1-positive lung adenocarcinomas, which appears to be in accordance with its deleterious functions in lung adenocarcinoma invasion and metastasis, as well as with the paradoxical association of TTF-1 expression with favourable prognosis in lung adenocarcinoma patients.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1016/j.ccr.2012.02.008
发表时间:
2012-03-20
期刊:
CANCER CELL
影响因子:
50.3
作者:
[Yamaguchi, Tomoya, Yanagisawa, Kiyoshi, Takahashi, Takashi]
通讯作者:
Takahashi, Takashi
DOI:
10.1038/emboj.2011.416
发表时间:
2012-01-18
期刊:
EMBO JOURNAL
影响因子:
11.4
作者:
[Hosono, Yasuyuki, Yamaguchi, Tomoya, Takahashi, Takashi]
通讯作者:
Takahashi, Takashi
Construction of scientific foundation for drug delivery technology using caveolae vesicles
-
批准号:19K22565
-
项目类别:Grant-in-Aid for Challenging Research (Exploratory)
-
资助金额:$4.16万
-
财政年份:2019
-
负责人:YAMAGUCHI Tomoya
-
依托单位:
Role of ROR1-mediated caveolae function in cell membrane organization and dynamics
-
批准号:18H02683
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.07万
-
财政年份:2018
-
负责人:YAMAGUCHI Tomoya
-
依托单位:
Lineage-specific survival signal of lung adenocarcinoma on the lung development master regulator
-
批准号:20790566
-
项目类别:Grant-in-Aid for Young Scientists (B)
-
资助金额:$2.75万
-
财政年份:2008
-
负责人:YAMAGUCHI Tomoya
-
依托单位:
国内基金
海外基金
登录
查看更多内容
MIR31HG通过结合转录终止因子TTF-1促进甲状腺癌恶性表型的机制研究
-
批准号:82002833
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:官青
-
依托单位:
lncRNALL18介导Wnt与TTF-1在高氧早产鼠BPD上皮细胞损伤修复中共活化机制的研究
-
批准号:81771621
-
项目类别:面上项目
-
资助金额:56.0万元
-
批准年份:2017
-
负责人:许巍
-
依托单位:
高胆固醇饮食对甲状腺功能的影响及TTF-1介导的分子机制
-
批准号:81300644
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2013
-
负责人:宋勇峰
-
依托单位:
TTF-1的表达与甲状腺乳头状癌的上皮间质转化及临床预后的相关性研究
-
批准号:81202114
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2012
-
负责人:白艳花
-
依托单位:
肺癌干细胞中OCT4、Nanog、Bmi-1和TTF-1主干基因的表达与功能研究
-
批准号:30872952
-
项目类别:面上项目
-
资助金额:34.0万元
-
批准年份:2008
-
负责人:董强刚
-
依托单位: